Sinclair Research, a leading provider of nonclinical contract research services, today announced a strategic partnership with Bolder BioPATH, a premier provider of pharmacology and pathology services specializing in in vivo models of Rheumatoid Arthritis, Osteoarthritis, Inflammatory Bowel Disease, and other autoimmune and inflammation models. "Bolder BioPATH has developed a portfolio of high-quality pharmacology mode
Bolder BioPATH is a Colorado-based contract pharmacology and pathology company that provides in vitro, model development, bioanalysis and related services.